DHT: topical vs systemic, proviron & 5-AR inhibitors

Quick recap: what DHT is

Dihydrotestosterone is testosterone's more potent cousin. The enzyme 5-alpha-reductase converts testosterone to DHT in tissues like the genitals, skin, and scalp, and DHT binds the androgen receptor with higher avidity, so locally it's the stronger androgenic signal. The one property that makes DHT genuinely different from testosterone is what it doesn't do: DHT does not aromatize to estradiol. Testosterone can convert to estrogen; DHT is a pure-androgen end-point. That's why people reach for it, and also why raising it systemically backfires in ways that aren't obvious - we get to that below. For the full picture of how DHT fits into libido and erections alongside free testosterone, estradiol, and prolactin, start with the parent guide: testosterone, DHT & sexual function. This page is the deep-dive on the four ways people actually manipulate DHT.

The four routes at a glance

Before the detail, here's how the delivery routes and agents compare. The evidence column is the honest part - it's uneven on purpose.

Systemic DHT - maintains, doesn't improve Mixed evidence

The cleanest test of what happens when you raise DHT throughout the body is a 24-month randomized, placebo-controlled trial of transdermal DHT in healthy older men (Sartorius and colleagues). Its own title carries the headline finding: male sexual function can be maintained without aromatization. In other words, when these men ran on DHT - which does not convert to estradiol - their sexual function held up, which is biologically interesting on its own. But the practical reading matters more: function was maintained, not improved, and the trial actually recorded a small decrease in overall sexual desire. Across a broad battery of sexual-function and mood measures, DHT did not deliver the upgrade people expect from "the most potent androgen."

The mechanism behind the underwhelming result is the same property that makes DHT attractive. Because exogenous DHT raises androgen levels body-wide, it suppresses your own testosterone production through normal feedback - and because DHT doesn't aromatize, it also lowers your estradiol. As the parent page covers, men need some estradiol for normal desire, so driving it down is a plausible reason desire dipped rather than rose. Put plainly: systemic DHT is not a libido upgrade. It's a non-aromatizing androgen that keeps the lights on while quietly dimming two of the other hormones that matter for how you feel. If anyone tells you injectable or transdermal DHT is a reliable way to feel more, the best controlled evidence we have says otherwise.

Topical / local DHT - a different question entirely Mixed evidence

Topical DHT is a separate idea from systemic DHT, and conflating them is where a lot of confusion starts. A DHT gel - marketed in some countries under names like Andractim - is used in specific clinical contexts for a localized effect: certain forms of hypogonadism, the management of gynecomastia, and some micropenis protocols, among others. The point of applying it locally is to get androgen action at the site, not to flood the bloodstream. Studies of transdermal DHT gel in aging men (for example Kunelius and colleagues) have looked at what happens when it's applied more broadly, and the recurring theme is the same trade-off as systemic use: meaningful DHT exposure comes with suppression of endogenous testosterone and estradiol.

The distinction to hold onto is local effect versus systemic levels. A gel intended for a localized clinical purpose is not the same intervention as deliberately raising whole-body DHT for "more androgen," and the evidence supporting a narrow clinical use does not transfer to general performance or libido goals. It's also worth knowing that DHT preparations are largely not approved in the US, so what circulates in non-clinical settings is unregulated. Topical DHT is a real tool in specific hands for specific problems; it is not a quietly superior way to "do testosterone without the estrogen."

Proviron (mesterolone) - mostly anecdote, named as such Mixed / Emerging

Proviron is the brand name for mesterolone, an oral DHT-derivative and a weak anabolic. Two uses come up constantly. The first is biochemical: mesterolone binds SHBG, the protein that locks up much of your testosterone, so the theory is that it "frees up" more of your existing testosterone into the usable fraction - which connects directly to the free vs total testosterone story. The second is experiential: a long tradition of users describe better libido, mood, and a sense of well-being on it.

Here's the discipline this page is built on. The SHBG-binding mechanism is plausible, but modern controlled data on these specific uses is limited - much of what's cited is old or indirect. And the libido and well-being claims are overwhelmingly anecdotal: they come from people who are almost never running proviron alone. It's typically layered on TRT or a cycle, so any reported effect is confounded with the testosterone, the estradiol shifts, expectation, and everything else someone optimizing hormones is doing at the same time. Mirroring how the parent page handles DHT anecdotes: these are real things people report, worth naming rather than denying - but they are n-of-1 accounts, not evidence. Treat proviron's libido reputation as a hypothesis, not a proven effect.

5-alpha-reductase inhibitors - the strong evidence is on the downside Strong evidence

The fourth way people touch DHT is to block it. Finasteride and dutasteride are 5-alpha-reductase inhibitors: they stop testosterone converting to DHT, suppressing it body-wide. They're genuinely effective for their intended jobs - male-pattern hair loss and benign prostatic hyperplasia - because DHT is the androgen driving both. That part isn't in dispute.

The strong evidence here is about the cost. Suppressing DHT causes reduced libido or erectile dysfunction in a minority of men, and - the part that makes this consequential - a subset report persistent sexual symptoms that don't fully resolve after stopping (the phenomenon explored in work by Irwig and reviewed by Traish and others). The numbers are debated and the persistent-symptom group appears small, but the signal is real enough that it belongs in any honest discussion of touching DHT. The lesson cuts against the instinct of this whole topic: the clearest sexual finding about DHT is the downside of crashing it, not the upside of adding it. If you're managing hair loss while on androgens, that trade-off is exactly the one to weigh - covered in minimizing hair loss without nuking your DHT and from the libido side in testosterone, DHT & sexual function.

The honest synthesis - "I felt it" vs "it was shown"

Step back and the whole topic resolves into one tension. On one side is a persistent stream of anecdotal, single-user reports - forum posts and self-experimenters using injectable DHT or proviron describing firmer, more frequent erections, higher genital sensitivity, stronger drive, and occasionally a subjective sense of increased fullness while on it. On the other side is the controlled data: a null-to-slightly-negative 24-month RCT of systemic DHT, and only limited, dated controlled evidence for proviron's headline claims.

Both can be reported honestly, but they don't carry the same weight. The anecdotes are n-of-1 accounts with no control group: no placebo, no blinding, no isolation of DHT from the testosterone, estradiol shifts, expectation, and lifestyle that travel with it - because almost nobody runs DHT or proviron alone. There is no controlled head-to-head comparing DHT or proviron against another androgen for erectile performance, drive, or size. So the gap between the glowing stories and the flat trial result is exactly the gap between "I felt it" and "it was shown." Treat the reports as hypotheses, not evidence - and remember that systemic DHT measurably suppresses your own testosterone and estradiol, which is the mechanism behind the decrease in desire the controlled trial actually recorded. If you experiment anyway, the defensible move is to do it like an experiment: a clear question, labs around it, and honesty about what you can and can't attribute. This sits downstream of getting the fundamentals right first, the same earn-your-baseline logic that runs through TRT vs HGH vs peptides.

What this means in practice

If your interest in DHT comes from low libido or sexual symptoms on otherwise-reasonable testosterone, the productive move is almost never "add DHT." It's to read the whole hormonal picture - free testosterone, estradiol kept in a healthy band rather than minimized, prolactin not elevated, and DHT not suppressed - and only consider DHT after hypogonadism is excluded. The sexual-function guide lays out that panel, estradiol management covers the hormone systemic DHT quietly lowers, and the bloodwork guide covers lab-day timing. For the broader question of why a "normal" number can still feel wrong, see normal testosterone, still feel low. And if any of this is on your radar because of side effects, the side-effects guide is the place to start.